Related Experiment Video
Updated: Aug 9, 2026

Measuring Cell Cycle Progression Kinetics with Metabolic Labeling and Flow Cytometry
Published on: May 22, 2012
The cell cycle: Probing new molecular determinants of resistance and sensitivity to cytotoxic agents
1Department of Hematology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Abstract:
The introduction of chemotherapy in the fifth and sixth decades of this century has resulted in the development of curative therapeutic interventions for patients with several types of solid tumors and hematopoietic neoplasms. The important obstacles encountered in the use of chemotherapy have been toxicity on the normal tissues of the body and the presence of mutations that confer resistance to these chemotherapeutic agents. During the past 5 years, the application of molecular analysis to the DNA of normal and neoplastic cells has uncovered some of the mechanisms through which chemotherapy induces cell death, and the changes within these cells that can confer either sensitivity or resistance to these cells. This new level of understanding of the mechanisms through which chemotherapy works, and by which genetic change can result in resistance to this therapy, has opened the door to totally new paradigms of treatment. These paradigms use molecular, genetic, and biologic therapies together to increase the sensitivity of abnormal cells to treatment, and to protect the normal tissues of the body from therapy-induced side effects. The implementation of these new strategies, which is already well under way, promises to dramatically change the way in which therapy is delivered over the next few years, and to improve the outcome especially in patients with neoplasms that currently are resistant to conventional dose therapy.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Related Concept Videos
Positive Regulator Molecules
Inhibition of Cdk Activity
Treatment Resistant Cancers
DNA Damage Can Stall the Cell Cycle
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...